Semaglutide (Generic for Wegovy®)

Semaglutide Weight Loss Program

VIP Doc's Semaglutide Weight Loss Program includes:

- Physician Consultation
  - Intake with the medical provider
  - Services are limited to weight loss and weight loss medications.
  - Patient EHR portal is available.
- Medication
  - Weekly semaglutide injections
    Injection given weekly in the medical setting
  - Home injections*
    Weekly injections by self-injecting at home with a Semaglutide Home Kit
    
    *Semaglutide Home Kit required
    
    *NV and AZ only
  - Provider Additional Medications
    The provider may recommend additional medications to facilitate weight loss
    
    Prescriptions and care are limited to weight loss
    
    Some recommended products and services require additional fees including labs and kits.
- Diet and Exercise
  - Weight loss programs benefit from a combination of exercise and healthy diets.

Call for appointment:

702-763-3789

VIP Docs Semaglutide Weight Loss Program

Our program includes:

- Physician Consultation (In person or telemedicine online).
- 4 weekly Semaglutide injections.
  - In office
  - For those who prefer the convenience of self-administering injections at home, we offer a Semaglutide Home kit.

Labs are recommended:

Labs help you provider ...
Patients participation in one of our weight loss programs receive discounts on our labs and packages.

Instructions for Semaglutide

This medication helps with weight loss by reducing your appetite. It's important to increase the dosage gradually over time.

Step-by-step dosage increase:

Start with 0.25mg weekly for the first 4 weeks.
Increase to 0.5mg weekly for the next 4 weeks.
Then, go up to 1mg weekly for the following 4 weeks.
The maximum dosage is 2.4mg* weekly, but this might vary depending on individual needs.

*A dosage of 1mg weekly strikes a good balance between effectiveness and reduced side effects, but this varies from patient to patient. Always consult your medical professional if you have questions or concerns.

More Services

Weight Loss Kit

sub

Semaglutide

sub

LDN

sub

What is Semaglutide

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist that provides numerous health benefits. It stimulates insulin release and suppresses glucagon secretion, regulating blood sugar levels, making it an effective treatment option for weight management and overall health improvement.

Semaglutide the ingredient in Wegovy a medicine that doctors use to help people lose weight. It works by copying a hormone in your body, which controls your appetite. When you take this medicine, you might feel less hungry, so you may end up eating less. This can lead to weight loss over time.

Possible Side-effects of Semaglutide

Disclaimer
- Disclaimer:
- The following list of potential side effects is not guaranteed to be exhaustive, complete, or applicable to every individual. The effects mentioned below are provided for informational purposes only and should not be considered as medical advice. It is important to consult with a healthcare professional before starting or discontinuing any medication.
- Individual Reactions: Each person may react differently to the medication, and the severity and occurrence of side effects may vary.
- Uncommon Side Effects: There may be additional, rare side effects that are not listed here. If you experience any unexpected symptoms while taking this medication, please consult a healthcare professional.
- Known Side Effects: The side effects mentioned below are those commonly reported during clinical trials and post-marketing surveillance. However, it is possible that not all potential side effects have been identified.
- Reporting Side Effects: If you experience any side effects, whether listed or unlisted, it is essential to report them to your healthcare provider or regulatory authorities in order to contribute to ongoing safety monitoring.
- Allergic Reactions: Allergic reactions to medications can occur, although they are rare. If you experience signs of an allergic reaction, such as difficulty breathing, hives, or swelling of the face or throat, seek immediate medical attention.
- Pre-existing Conditions: The side effects and safety profile of this medication may differ for individuals with pre-existing medical conditions. Please inform your healthcare provider of any pre-existing conditions or ongoing medications before starting this treatment.
- Other Factors: It is important to note that factors such as age, overall health, and concurrent medications can influence the occurrence and severity of side effects.
Remember, this disclaimer is intended as a general guideline and should be customized to fit your specific medication and circumstances. It is always recommended to seek professional advice and review the product information provided by the manufacturer or regulatory authorities. You can read more about Semaglutide at https://www.ozempic.com/how-to-take/ozempic-dosing.html#footer-isi-container and https://www.novo-pi.com/wegovy.pdf#guide

Remember, this disclaimer is intended as a general guideline and should be customized to fit your specific medication and circumstances. It is always recommended to seek professional advice and review the product information provided by the manufacturer or regulatory authorities. You can read more about Semaglutide at https://www.ozempic.com/how-to-take/ozempic-dosing.html#footer-isi-container and https://www.novo-pi.com/wegovy.pdf#guide
Common Mild Side Effects
- Nausea (up to 44% of patients)
- Vomiting (up to 24% of patients)
- Diarrhea (up to 30% of patients)
- Abdominal pain (up to 20% of patients)
- Constipation (up to 24% of patients)
- Increased amylase (up to 13% of patients)
- Increased lipase (up to 22% of patients)
- Dyspepsia (1% to 10% of patients)
- Eructation (1% to 10% of patients)
- Flatulence (1% to 10% of patients)
- Gastroesophageal reflux disease (1% to 10% of patients)
- Abdominal distention (1% to 10% of patients)
- Gastroenteritis (1% to 10% of patients)
- Gastritis (1% to 10% of patients)
Common Severe Side Effects
- Anxiety
- Bloating
- Blurred vision
- Chills
- Cold sweats
- Confusion
- Constipation
- Cool, pale skin
- Cough
- Darkened urine
- Depression
- Difficulty swallowing
- Dizziness
- Fast heartbeat
- Fever
- Headache
- Increased hunger
- Indigestion
- Large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
- Loss of appetite
- Nausea
- Nervousness
- Nightmares
- Pain in the stomach, side, or abdomen, possibly radiating to the back
- Seizures
- Skin rash
- Slurred speech
- Tightness in the chest
- Trouble breathing
- Unusual tiredness or weakness
- Vomiting
- Yellow eyes or skin
Rare Side Effects
- Anaphylactic reaction (less than 0.1% of patients)
- Angioedema
- Rash
Additional Side Effects
- Hypoglycemia (up to 30% when used in combination with basal insulin, 1% to 10% otherwise)
- Decreased appetite (1% to 10% of patients)
- Weight loss (1% to 10% of patients)
- Complications of diabetic retinopathy (1% to 10%, higher in patients with a history of diabetic retinopathy)
- Medullary thyroid cancer (reported in postmarketing period, but data insufficient to establish or exclude a causal relationship)

Contraindications

Certain individuals should avoid using Semaglutide, including those who have:

Pancreatitis
A personal history of thyroid cancer
Multiple Endocrine Neoplasia Syndrome Type II
Are currently pregnant or breastfeeding
Allergy to GLP-1 Medications

Semaglutide may increase the risk of hypoglycemia (low blood sugar), especially when taken with other diabetes medications. The US Food and Drug Administration (FDA) has issued a "black box" warning for Ozempic, a brand name for semaglutide, due to potential increased risk of thyroid tumors in animal studies.